| Title | Current Drug Targets |
| Abbreviation | Curr. Drug Targets |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3) |
| h-index | 119 |
| Overall Rank/Ranking | 7587 |
| SCImago Journal Rank (SJR) | 0.691 |
| Impact Score | 2.96 |
| Publisher | Bentham Science Publishers B.V. |
| Country | United Arab Emirates |
| ISSN | 18735592, 13894501 |
| Best Quartile | Q2 |
| Coverage History | 2000-2023 |
Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal is devoted to a single timely topic, with series of in-depth reviews, written by leaders in the field, covering a range of current topics on drug targets. These issues are organized and led by a Guest Editor who is a recognized expert in the overall topic. As the discovery, identification, characterisation and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.
Current Drug Targets is a journal covering the technologies/fields/categories related to Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3). It is published by Bentham Science Publishers B.V.. The overall rank of Current Drug Targets is 7587. According to SCImago Journal Rank (SJR), this journal is ranked 0.691. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 119. The best quartile for this journal is Q2.
The ISSN of Current Drug Targets journal is 18735592, 13894501. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Current Drug Targets is cited by a total of 1214 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Current Drug Targets is 2.96, which is computed in 2024 as per its definition. Current Drug Targets IF is decreased by a factor of 0.17 and approximate percentage change is -5.43% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Current Drug Targets is 2.96. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 2.96 |
| 2022 | 3.13 |
| 2021 | 2.88 |
| 2020 | 3.06 |
| 2019 | 2.59 |
| 2018 | 2.22 |
| 2017 | 2.12 |
| 2016 | 2.58 |
| 2015 | 3.19 |
| 2014 | 3.19 |
Current Drug Targets has an h-index of 119. It means 119 articles of this journal have more than 119 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Current Drug Targets is 18735592, 13894501. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Current Drug Targets is 7587. According to SCImago Journal Rank (SJR), this journal is ranked 0.691. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.691 |
| 2022 | 0.621 |
| 2021 | 0.654 |
| 2020 | 0.826 |
| 2019 | 0.741 |
| 2018 | 0.825 |
| 2017 | 0.906 |
| 2016 | 1.172 |
| 2015 | 1.219 |
| 2014 | 1.395 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 7587 |
| 2022 | 8234 |
| 2021 | 7427 |
| 2020 | 5784 |
| 2019 | 6507 |
| 2018 | 5669 |
| 2017 | 4998 |
| 2016 | 3471 |
| 2015 | 3340 |
| 2014 | 2593 |
Current Drug Targets is published by Bentham Science Publishers B.V.. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2000-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Current Drug Targets is Curr. Drug Targets. This abbreviation ('Curr. Drug Targets') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Current Drug Targets latest impact IF is 2.96. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 3.19 (2015) and 2.12 (2017), respectively, in the last 10 years. Moreover, its average IS is 2.79 in the previous 10 years.
The Current Drug Targets has an SJR (SCImago Journal Rank) of 0.691, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.395 in 2014 and the lowest being 0.621 in 2022. Furthermore, the average SJR of the Current Drug Targets over the previous 10-year period stands at 2.79.
The latest h-index of the Current Drug Targets is 119.
The Current Drug Targets is published by the Bentham Science Publishers B.V., with its country of publication being the United Arab Emirates.
The Current Drug Targets is currently ranked 7587 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 2593 in 2014 and its lowest position of 8234 in 2022.
The standard ISO4 abbreviation for the Current Drug Targets is Curr. Drug Targets.
Current Drug Targets is classified as a journal that the Bentham Science Publishers B.V. publishes.
The Current Drug Targets encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Current Drug Targets is assigned the following International Standard Serial Numbers (ISSN): 18735592, 13894501.
The best quartile for the Current Drug Targets is Q2 (2023).
The Current Drug Targets coverage history can be summarized as follows: 2000-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Dermatologia Kliniczna | journal | 25442 | Cornetis | 7 | 0.00 |
| Historia | journal | 28724 | Universidade Estadual Paulista | 8 | 0.02 |
| Clinical Medicine and Research | journal | 14722 | Marshfield Clinic | 62 | 1.02 |
| Entrepreneurship Theory and Practice | journal | 220 | Wiley-Blackwell | 198 | 15.69 |
| Materials Research | journal | 15375 | Universidade Federal de Sao Carlos | 71 | 1.46 |
| International Journal of Parallel, Emergent and Distributed Systems | journal | 16153 | Taylor and Francis Ltd. | 25 | 1.10 |
| Sex Education | journal | 7722 | Routledge | 45 | 2.66 |
| European Surgery - Acta Chirurgica Austriaca | journal | 18870 | Springer Medizin | 24 | 0.60 |
| Sapporo Medical Journal | journal | 27142 | 3 | 0.00 | |
| Genes and Nutrition | journal | 5793 | BioMed Central Ltd | 65 | 3.42 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 2.96 |
| 2022 | 3.13 |
| 2021 | 2.88 |
| 2020 | 3.06 |
| 2019 | 2.59 |
| 2018 | 2.22 |
| 2017 | 2.12 |
| 2016 | 2.58 |
| 2015 | 3.19 |
| 2014 | 3.19 |
